Intraperitoneal chemotherapy as first-line treatment of newly diagnosed advanced epithelial ovarian cancer: Two centers' data in China

被引：0
|
作者：
Xie, X. [1 ]
Shen, Y. [1 ]
Tang, S. [1 ]
Cheng, X. [1 ]
Lv, W. [1 ]
Wan, X. [1 ]
Chen, Z. [2 ]
机构：
[1] Zhejiang Univ, Sch Med, Womens Hosp, Hangzhou, Peoples R China
[2] Zhejiang Canc Hosp, Hangzhou, Zhejiang, Peoples R China
来源：
GYNECOLOGIC ONCOLOGY | 2020年 / 159卷
关键词：
D O I：
10.1016/j.ygyno.2020.05.649
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
761
引用
收藏
页码：348 / 348
页数：1
相关论文
共 50 条
  • [31] Addition of intraperitoneal cisplatin and etoposide to first-line chemotherapy for advanced ovarian cancer: a randomised, phase 2 trial
    Shi, Tingyan
    Jiang, Rong
    Yu, Jinjin
    Yang, Huijuan
    Tu, Dongsheng
    Dai, Zhiyuan
    Shen, Yang
    Zhang, Yuqin
    Cheng, Xi
    Jia, Huixun
    Tu, Ruiqin
    Wang, Huaying
    Tang, Jie
    Luan, Yuting
    Cai, Shumo
    Zang, Rongyu
    BRITISH JOURNAL OF CANCER, 2018, 119 (01) : 12 - 18
  • [32] Intraperitoneal chemotherapy in the treatment of advanced ovarian cancer
    Classe, J. -M.
    Muller, M.
    Frenel, J. -S.
    Rigaud, D. Berton
    Ferron, G.
    Jaffre, I.
    Gladieff, L.
    JOURNAL DE GYNECOLOGIE OBSTETRIQUE ET BIOLOGIE DE LA REPRODUCTION, 2010, 39 (03): : 183 - 190
  • [33] First-line chemotherapy for advanced ovarian cancer: paclitaxel, cisplatin and the evidence
    Sandercock, J
    Parmar, MKB
    Torri, V
    BRITISH JOURNAL OF CANCER, 1998, 78 (11) : 1471 - 1478
  • [34] The impact of age on first-line chemotherapy treatment of epithelial ovarian cancer and primary peritoneal carcinoma
    Larbi, E.
    Madhuri, T. K.
    Essapen, S.
    Michael, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [35] First-line chemotherapy for advanced ovarian cancer: paclitaxel, cisplatin and the evidence
    J Sandercock
    MKB Parmar
    V Torri
    British Journal of Cancer, 1998, 78 : 1471 - 1478
  • [36] REASONS FOR TUMOR RESIDUALS BEFORE STARTING FIRST-LINE CHEMOTHERAPY IN ADVANCED EPITHELIAL OVARIAN CANCER (AOC).
    Heitz, F.
    Harter, P.
    Beutel, B.
    Traut, A.
    Ataseven, B.
    Schneider, S.
    Christian, K.
    Sporkmann, M.
    du Bois, A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (09) : 1386 - 1386
  • [37] Docetaxel (D) and carboplatin with Auc-7 as first-line chemotherapy in advanced epithelial ovarian cancer
    Salimi, M
    Davaee, M
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S243 - S243
  • [38] Poly-(ADP-ribose) polymerase inhibitors: paradigm shift in the first-line treatment of newly diagnosed advanced ovarian cancer
    Haddad, Fady Gh
    Karam, Elias
    Moujaess, Elissar
    Kourie, Hampig Raphael
    PHARMACOGENOMICS, 2020, 21 (10) : 721 - 727
  • [39] Intraperitoneal carboplatin in icodextrin 4% as first-line treatment for epithelial ovarian cancer: A phase I/II trial
    Hofman, L.
    Sludden, J.
    Boddy, A. V.
    Murphy, D. J.
    Ferry, D. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [40] First-line rucaparib maintenance after hyperthermic intraperitoneal chemotherapy with interval debulking surgery for advanced epithelial ovarian cancer: a real-world study
    Palo, Upasana
    Mondal, Debapriya
    Roy, Somnath
    Bhattacharjee, Arnab
    Ghosh, Anik
    Chakraborti, Basumita
    Mishra, Jagannath
    Bhaumik, Jaydip
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_3) : A36 - A36
12345